MARKET

CAPR

CAPR

Capricor Therapeutics Inc
NASDAQ
6.34
-0.63
-9.04%
After Hours: 6.30 -0.04 -0.60% 19:58 05/09 EDT
OPEN
6.99
PREV CLOSE
6.97
HIGH
7.10
LOW
6.27
VOLUME
3.64M
TURNOVER
--
52 WEEK HIGH
23.40
52 WEEK LOW
3.520
MARKET CAP
289.59M
P/E (TTM)
-5.5178
1D
5D
1M
3M
1Y
5Y
1D
Healthcare stocks that could be poised for a rebound
Seeking Alpha · 1d ago
Vinay Prasad's Appointment To FDA's CBER Triggers Questions Over Future Of Cell And Gene Therapy Regulation
Benzinga · 3d ago
BUZZ-Gene therapy and vaccine makers fall after FDA names Vinay Prasad as top vaccine official
Reuters · 4d ago
U.S.-LISTED SHARES OF CRISPR THERAPEUTICS FALL 10.3%, SAREPTA THERAPEUTICS FALL 20.2%
Reuters · 4d ago
GENE THERAPY MAKERS FALL AFTER US FDA NAMES ONCOLOGIST VINAY PRASAD AS TOP VACCINE OFFICIAL
Reuters · 4d ago
Press Release: Capricor Therapeutics to Present First Quarter 2025 Financial Results and Recent Corporate Update on May 13
Dow Jones · 4d ago
Capricor FDA panel meeting ‘not unexpected,’ says JonesResearch
TipRanks · 5d ago
Capricor falls 12% as FDA orders panel to discuss Duchenne cardiomyopathy asset
Seeking Alpha · 5d ago
More
About CAPR
More
Capricor Therapeutics, Inc. is a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment and prevention of rare diseases. The Company's program is focused on the development and commercialization of a cell therapy technology comprised of cardiosphere-derived cells (CDCs) for the treatment of Duchenne muscular dystrophy (DMD). Its lead product candidate deramiocel (also referred to as CAP-1002), is an allogeneic cardiac-derived cell therapy. CAP-1002 is advancing through Phase III clinical development for the treatment of Duchenne muscular dystrophy (DMD). CAP-1002 demonstrates immunomodulatory, antifibrotic, and regenerative actions specifically tailored for dystrophinopathies and heart disease. It leverages its exosome technology, using its StealthX platform in preclinical development focused on the areas of vaccinology, targeted delivery of oligonucleotides, proteins, and small molecule therapeutics.
Recently
Symbol
Price
%Change

Webull offers Capricor Therapeutics Inc stock information, including NASDAQ: CAPR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CAPR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CAPR stock methods without spending real money on the virtual paper trading platform.